| 2026-09-22 | Trial | New trial registered: Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes | Trial register ClinicalTrials.gov |
| 2026-09-15 | Trial | New trial registered: Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial | Trial register ClinicalTrials.gov |
| 2026-08-18 | Trial | New trial registered: GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry | Trial register ClinicalTrials.gov |
| 2026-07-14 | Trial | New trial registered: Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2026-07-08 | Results | Results posted: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-07-01 | Trial | New trial registered: Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2026-06-25 | Trial | New trial registered: A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-06-16 | Label | FDA label revised: Trulicity (BLA125469) | Regulator FDA drug label register |
| 2026-06-02 | Trial | New trial registered: Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk | Trial register ClinicalTrials.gov |
| 2026-04-17 | Trial | New trial registered: Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney D | Trial register ClinicalTrials.gov |
| 2026-02-18 | Trial | New trial registered: Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data. | Trial register ClinicalTrials.gov |
| 2026-02-18 | Trial | New trial registered: INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD) | Trial register ClinicalTrials.gov |
| 2026-01-27 | Trial | New trial registered: Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia | Trial register ClinicalTrials.gov |
| 2026-01-06 | Trial | New trial registered: Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2026-01-02 | Trial | New trial registered: A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2025-12-30 | Trial | New trial registered: Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD | Trial register ClinicalTrials.gov |
| 2025-12-18 | Trial | New trial registered: Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists | Trial register ClinicalTrials.gov |
| 2025-12-15 | Trial | New trial registered: Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis | Trial register ClinicalTrials.gov |
| 2025-12-05 | Results | Results posted: Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy | Trial register ClinicalTrials.gov |
| 2025-11-29 | Trial | New trial registered: Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention | Trial register ClinicalTrials.gov |
| 2025-09-16 | Trial | New trial registered: Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Out | Trial register ClinicalTrials.gov |
| 2025-09-05 | Trial | New trial registered: A Phase 3 Study of HS-20094 in Patients With T2DM | Trial register ClinicalTrials.gov |
| 2025-08-07 | Trial | New trial registered: A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin | Trial register ClinicalTrials.gov |
| 2025-08-03 | Results | Results posted: A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) | Trial register ClinicalTrials.gov |
| 2025-07-31 | Trial | New trial registered: Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk | Trial register ClinicalTrials.gov |
| 2025-07-28 | Trial | New trial registered: Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data | Trial register ClinicalTrials.gov |
| 2025-07-03 | Label | FDA label revised: TRULICITY (BLA125469) | Regulator FDA drug label register |
| 2025-06-11 | Trial | New trial registered: Metabolic Surgery for Atrial Fibrillation Elimination | Trial register ClinicalTrials.gov |
| 2025-04-20 | Results | Results posted: Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease | Trial register ClinicalTrials.gov |
| 2025-03-30 | Trial | New trial registered: A Study of HS-20094 in Patients With T2DM | Trial register ClinicalTrials.gov |
| 2025-02-28 | Trial | New trial registered: Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. | Trial register ClinicalTrials.gov |
| 2025-02-05 | Results | Results posted: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India | Trial register ClinicalTrials.gov |
| 2025-01-17 | Results | Results posted: Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients | Trial register ClinicalTrials.gov |
| 2025-01-17 | Trial | New trial registered: Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabete | Trial register ClinicalTrials.gov |
| 2025-01-14 | Results | Results posted: A Study of LY3493269 in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2024-12-18 | Trial | New trial registered: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) | Trial register ClinicalTrials.gov |
| 2024-12-05 | Results | Results posted: GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response | Trial register ClinicalTrials.gov |
| 2024-09-25 | Trial | New trial registered: The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diab | Trial register ClinicalTrials.gov |
| 2024-09-03 | Trial | New trial registered: GLP_1 RA Ultrasound Study | Trial register ClinicalTrials.gov |
| 2024-07-15 | Trial | New trial registered: Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery | Trial register ClinicalTrials.gov |
| 2024-06-27 | Trial | New trial registered: Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy | Trial register ClinicalTrials.gov |
| 2024-06-07 | Trial | New trial registered: Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh | Trial register ClinicalTrials.gov |
| 2024-05-30 | Results | Results posted: Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients | Trial register ClinicalTrials.gov |
| 2024-03-26 | Trial | New trial registered: The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity | Trial register ClinicalTrials.gov |
| 2024-03-22 | Trial | New trial registered: GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery | Trial register ClinicalTrials.gov |
| 2024-02-14 | Trial | New trial registered: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin | Trial register ClinicalTrials.gov |
| 2024-01-31 | Trial | New trial registered: A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2024-01-16 | Results | Results posted: A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) | Trial register ClinicalTrials.gov |
| 2023-12-27 | Trial | New trial registered: Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy | Trial register ClinicalTrials.gov |
| 2023-12-12 | Label | FDA label revised: Trulicity (BLA125469) | Regulator FDA drug label register |
| 2023-12-09 | Label | FDA label revised: Trulicity (BLA125469) | Regulator FDA drug label register |
| 2023-11-28 | Trial | New trial registered: Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2023-11-07 | Trial | New trial registered: Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes | Trial register ClinicalTrials.gov |
| 2023-10-17 | Results | Results posted: A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2023-09-21 | Results | Results posted: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2023-08-14 | Trial | New trial registered: Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years | Trial register ClinicalTrials.gov |
| 2023-08-05 | Label | FDA label revised: TRULICITY (BLA125469) | Regulator FDA drug label register |
| 2023-07-14 | Trial | New trial registered: Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) | Trial register ClinicalTrials.gov |
| 2023-07-03 | Results | Results posted: A Study of LY3437943 in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2023-05-24 | Results | Results posted: A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2023-05-03 | Label | FDA label revised: TRULICITY (BLA125469) | Regulator FDA drug label register |
| 2023-05-03 | Label | FDA label revised: TRULICITY (BLA125469) | Regulator FDA drug label register |
| 2023-01-11 | Trial | New trial registered: A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM | Trial register ClinicalTrials.gov |
| 2022-12-21 | Trial | New trial registered: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India | Trial register ClinicalTrials.gov |
| 2022-11-07 | Trial | New trial registered: A Study of IBI362 in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-10-03 | Trial | New trial registered: A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) | Trial register ClinicalTrials.gov |
| 2022-08-26 | Trial | New trial registered: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2022-08-08 | Trial | New trial registered: Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health | Trial register ClinicalTrials.gov |
| 2022-07-28 | Trial | New trial registered: Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-07-14 | Trial | New trial registered: A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects | Trial register ClinicalTrials.gov |
| 2022-07-01 | Results | Results posted: A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-06-07 | Trial | New trial registered: A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2022-05-25 | Recall | FDA recall, Class II: Cardinal Health Inc.. TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement w | Regulator FDA enforcement reports |
| 2022-05-25 | Recall | FDA recall, Class II: Cardinal Health Inc.. TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions | Regulator FDA enforcement reports |
| 2022-05-19 | Trial | New trial registered: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-05-17 | Trial | New trial registered: A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-04-27 | Trial | New trial registered: A Study of TG103 Injection in Type 2 Diabetes Subjects | Trial register ClinicalTrials.gov |
| 2022-04-14 | Results | Results posted: A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-02-24 | Trial | New trial registered: Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease | Trial register ClinicalTrials.gov |
| 2022-02-01 | Trial | New trial registered: Basal Plus GLP1-ra on Glycemic Variability in CKD | Trial register ClinicalTrials.gov |
| 2021-12-22 | Trial | New trial registered: Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study | Trial register ClinicalTrials.gov |
| 2021-12-01 | Trial | New trial registered: Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D | Trial register ClinicalTrials.gov |
| 2021-11-29 | Trial | New trial registered: SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECT | Trial register ClinicalTrials.gov |
| 2021-11-23 | Trial | New trial registered: BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes | Trial register ClinicalTrials.gov |
| 2021-11-01 | Results | Results posted: Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | Trial register ClinicalTrials.gov |
| 2021-09-17 | Trial | New trial registered: A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2021-09-01 | Recall | FDA recall, Class II: Eli Lilly & Company. Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL | Regulator FDA enforcement reports |
| 2021-08-13 | Trial | New trial registered: The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. | Trial register ClinicalTrials.gov |
| 2021-07-16 | Trial | New trial registered: A Study of IBI362 in Chinese Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-05-19 | Trial | New trial registered: Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-04-30 | Trial | New trial registered: A Study of LY3437943 in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-04-29 | Trial | New trial registered: GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS) | Trial register ClinicalTrials.gov |
| 2021-04-27 | Trial | New trial registered: Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients | Trial register ClinicalTrials.gov |
| 2021-04-02 | Trial | New trial registered: Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin | Trial register ClinicalTrials.gov |
| 2021-03-22 | Trial | New trial registered: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-02-17 | Results | Results posted: Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc | Trial register ClinicalTrials.gov |
| 2021-01-29 | Trial | New trial registered: GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance | Trial register ClinicalTrials.gov |
| 2020-12-29 | Trial | New trial registered: Effects of Glucagon-Like Peptide-1 Analogs on Sexuality | Trial register ClinicalTrials.gov |
| 2020-11-23 | Trial | New trial registered: A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2020-11-10 | Results | Results posted: Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? | Trial register ClinicalTrials.gov |